Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: an observational study. (December 2021) - Storm, B.; Abedian Kalkhoran, H.; Wilms, E.; Brocken, P.; Codrington, H.; Houtsma, D.; Portielje, J.; de Glas, N.; van der Ziel, D.; van den Bos, F.; Visser, L.